Cryocath Technologies Inc


in
Cryocath Technologies Inc. announced the introduction of Arctic Front(R) in Italy, Belgium and Spain. Arctic Front, the company's lead product for the treatment of paroxysmal atrial fibrillation (PAF), is a unique cryoablation balloon catheter that allows physicians to safely and effectively isolate all four pulmonary veins for the treatment of PAF. The first Arctic Front procedures in Belgium were performed in May 2008 by Prof. Dr. Pedro Brugada, Head of the Heart Rhythm Management Centre, UZ Brussel-Vrije Universiteit Brussel and Dr. Gian Battista Chierchia, Director Atrial Fibrillation and Pacing Program. Drs. Brugada and Chierchia have treated four patients in Brussels to date.
, M.D., in 2003. They published their findings in Neuron in March 2005, reporting that brain imaging studies indicate that Brodmann Area 25 appears to be overactive in profoundly sad and depressed people.